Dr Reddy's COO On US Derma Build-Up, One-Sided Biologics Norms
This article was originally published in Scrip
Executive Summary
Dr Reddy's Laboratories (DRL) appears to be building on plans for its differentiated dermatology and neurology formulations in the US after gains on the approvals front.